MedPath

浙江华津依科生物制药有限责任公司

Ownership
-
Established
2004-01-19
Employees
-
Market Cap
-
Website
www.hjykbio.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Lyophilized Mouse Epidermal Growth Factor(mEGF)

Product Name
一夫
Approval Number
国药准字S20020043
Approval Date
Jun 22, 2021
NMPA

Thymopolypeptides for Injection

Product Name
注射用胸腺肽
Approval Number
国药准字H20003542
Approval Date
Mar 17, 2021
NMPA

Thymopolypeptides for Injection

Product Name
注射用胸腺肽
Approval Number
国药准字H20003541
Approval Date
Mar 17, 2021
NMPA

Thymopolypeptides for Injection

Product Name
注射用胸腺肽
Approval Number
国药准字H20003540
Approval Date
Mar 11, 2021
NMPA

Ramosetron Hydrochloride Injection

Product Name
盐酸雷莫司琼注射液
Approval Number
国药准字H20064329
Approval Date
Dec 14, 2020
NMPA

Ganciclovir for Injection

Product Name
注射用更昔洛韦
Approval Number
国药准字H20064437
Approval Date
Nov 30, 2020
NMPA

丁公藤注射液

Approval Number
国药准字Z20053979
Approval Date
May 12, 2005
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.